-
Taxonomy & unit
-
us-gaap: CAD and USD
-
Description
-
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
-
Summary
-
Intellipharmaceutics International Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2010 to Q4 2022.
- Intellipharmaceutics International Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending November 30, 2022 was $27.4M, a 2.6% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)